I.    PURPOSE

As a means of enhancing the health and safety of its students, staff and visitors, Minnetonka Public Schools will obtain, possess and administer doses of an opiate antagonist (naloxone and/or Narcan) and administration devices or kits for emergency use to assist a student, staff member, or other individual believed or suspected to be experiencing an opioid overdose on school district property during the school day or at school district activities.

II.    GENERAL STATEMENT

It is the intent of the Minnetonka School District to provide assistance to any person(s) who may be suffering from an opioid overdose following protocols and procedures of the school district if the staff member determines in good faith that the person to whom the medication is administered is experiencing an opioid overdose. Authorization for obtaining, possessing and administering Naloxone or similar permissible medications under this policy are contingent upon: 1) the continued validity of state and federal law that permit a person who is not a healthcare professional to dispense an opiate antagonist; 2) that the school district and its staff are immune from criminal prosecution and not otherwise liable for civil damages for administering the opiate antagonist to another person who the staff member believes in good faith to be suffering from a drug overdose. Staff members trained in accordance with the procedure shall make every reasonable effort to include the use of naloxone combined with rescue breaths to revive the victim of any apparent opioid overdose.

III.    DEFINITIONS

1. “Good Samaritan” Minnesota Statute (604A.04) “Good Samaritan Overdose Protection” allows for “A person who is not a healthcare professional who acts in good faith in administering an opiate antagonist to another person whom the person believes in good faith to be suffering an opioid overdose is immune from criminal prosecution for the act and is not liable for any civil damages for acts or omissions resulting from the act.”
    
2. “Drug-related overdose” means an acute condition, including mania, hysteria, extreme physical illness, respiratory depression or coma, resulting from the consumption or use of a controlled substance, or another substance with which a controlled substance was combined, and that a layperson would reasonably believe to be a drug overdose that requires immediate medical assistance.
    
3. “Opiate” means any dangerous substance having an addiction forming or addiction sustaining liability similar to morphine or being capable of conversion into a drug having such addiction forming or addiction sustaining liability.
    
4. “Opiate Antagonist” means naloxone hydrochloride (“Naloxone”) or any similarly acting drug approved by the federal Food and Drug Administration for the treatment of a drug overdose.
    
5. “Standing Order” means directions from the school district’s medical provider that sets forth how to house and administer Naloxone or other Opiate Antagonist medications to students, staff members or other individuals believed or suspected to be experiencing an opioid overdose. This Standing Order should include the following information:
    
   1. Administration type
   2. Dosage
   3. Date of issuance
   4. Signature of the authorized provider

IV.    REQUIREMENTS

1. The District will obtain a standing order for naloxone by a licensed medical prescriber and update as needed.
    
2.  Stock naloxone will be clearly labeled and stored in a secured location that is accessible by trained staff.
    
3. The Director of Health Services and/or School Administration will identify appropriate staff to be trained annually at each school site.
    
   1. Regardless of the service delivery model, the licensed school nurse is always the lead of the school health services team and may determine which school personnel are to be given the responsibility of administering naloxone.
       
4. Training for designated school staff will be conducted annually and will include:
    
   1. Signs and symptoms of opioid overdose
   2. Appropriate administration of naloxone
   3. Activation of emergency personnel
   4. Notification procedures

V.    GENERAL STATEMENT OF RESPONSIBILITIES

1. The school district must maintain a supply of opiate antagonists at each school site to be administered in compliance with Minnesota law. Each school building must have two doses of nasal naloxone available on-site.
    
2. A licensed physician, a licensed advanced practice registered nurse authorized to prescribe drugs pursuant to Minnesota Statutes, section 148.235, or a licensed physician assistant may authorize a nurse or other personnel employed by, or under contract with, a public school may be authorized to administer opiate antagonists as defined under Minnesota Statutes, section 604A.04, subdivision 1.
    
3. A licensed practical nurse is authorized to possess and administer an opiate antagonist in a school setting notwithstanding Minnesota Statutes, 148.235, subdivisions 8 and 9.

VI.    NOTIFICATION PROCEDURES

In the event of naloxone administration and emergency response activation, the following people must be notified:

1. Superintendent
2. Associate Superintendent
3. Executive Director of Communication
4. Director of Health Services
5. Building Principal
6. School Counselor, Psychologist, and/or Social Worker
7. Licensed School Nurse
8. Licensed Alcohol and Drug Counselor
9. School Resource Officer(s)
10. Parents/guardians

VII.    STORAGE/ACCESS

1. Stock naloxone will be clearly labeled and stored in a secure location accessible by trained personnel.
    
2. Stock naloxone will only be available at the schools during typical school hours. It will not be sent on field trips and will not be available for activities that occur outside of the typical school day.
    
3. The selected storage locations of Naloxone will be classified as non-public “security information". The identity of the storage locations will be shared only with those school district staff members whom District administration have determined need access to this information to aid public health and safety as determined in the procedures and guidelines.

VIII.    MAINTENANCE

The Licensed School Nurse and/or Director of Health Services will monitor and track expiration dates of the naloxone and will be replaced as needed.

IX.    PRIVACY PROTECTIONS

Legal References